Workflow
退市风险
icon
Search documents
退市倒计时下的*ST华微:控股股东火线易主谋自救
Xin Lang Zheng Quan· 2025-06-20 08:41
Group 1 - The company *ST Huamei is facing a critical situation with delisting risks and is attempting to resolve issues through a "lightning transfer" of control rights [1] - The controlling shareholder, Shanghai Pengsheng, is planning to transfer its shares, which may lead to a change in control, with trading suspension effective from June 19 for no more than two trading days [1] - There is a significant non-operating fund occupation issue amounting to 1.491 billion yuan that has persisted since 2015, which must be resolved by August 12 to avoid delisting risks [1] Group 2 - The controlling shareholder has pledged all shares (approximately 214 million shares, valued at 1.682 billion yuan) as repayment collateral, but substantial progress remains unclear [2] - The company has announced a rectification plan, including the disposal of controlling shareholder shares and potential legal actions [2] - Market speculation about potential buyers focuses on three categories: industrial capital interested in its IDM semiconductor manufacturing capabilities, local state-owned assets from Jilin, and financial investors betting on restructuring opportunities [2] Group 3 - The crisis stems from a funding black hole and years of information disclosure violations, leading to a loss of trust [3] - From 2015 to 2023, the company failed to disclose fund occupation accurately, resulting in fines totaling 20 million yuan and lifetime bans for several executives [3] - Despite a revenue of 2.058 billion yuan in 2024 and a net profit increase of 246%, the auditing firm expressed doubts about the recoverability of funds, issuing an "unable to express an opinion" report [3]
终止上市!*ST恒立年报“难产”真相揭开面纱
另外,《处罚》针对*ST恒立未按期披露2024年年报的事项,行政处罚拟对公司责令改正、给予警告并 处以350万元罚款,对相关责任人给予警告并处以100万元—180万元金额不等的罚款。 *ST恒立(000622)退市"尘埃落定"。 6月17日,因未在法定期限内披露过半数董事保证真实、准确、完整的2024年年报,*ST恒立收到终止 上市决定。 值得注意的是,在收到深交所退市决定的同时,*ST恒立收到湖南证监局下发的《行政处罚事先告知 书》(下称《处罚》),《处罚》揭示了公司未按期披露2024年年报的真实原因。 6月17日,因未在法定期限内披露过半数董事保证真实、准确、完整的2024年年报,*ST恒立收到终止 上市决定。 回溯*ST恒立发展历程,此次退市是长期经营不善、叠加严重违规问题、公司治理缺陷等多重因素导致 的结局。上市以来,公司经营过冷气设备,生产过新能源电池。2018年以来,公司设备生产主业大幅萎 缩,主要业务转向委托加工及贸易,盈利能力持续承压,深陷亏损泥潭,甚至收入也逼近退市红线。 2024年,公司将保壳赌注押宝在注入新余锂想新能源有限公司,收购后公司第四季度突击增加收入超过 2亿元。从年审机构提出的 ...
缺少经营所需启动资金,众泰汽车再面临退市风险,净资产骤降超80%
Mei Ri Jing Ji Xin Wen· 2025-06-18 10:58
Core Viewpoint - Zhongtai Automobile is facing significant risks of delisting due to a lack of operational funds, resulting in no vehicle production this year and a potential negative net asset situation by the end of 2025 [1][4]. Financial Performance - As of June 18, 2025, Zhongtai Automobile's stock price was 2.07 yuan per share, with a market capitalization of 10.438 billion yuan [5]. - The company's net assets were reported at 234 million yuan at the end of 2024, down from 1.235 billion yuan the previous year, marking a decline of 80.98% due to a net profit loss of 1 billion yuan [6]. - By the end of Q1 2025, net assets further decreased to 131 million yuan, a drop of 43.88% from the previous year, primarily due to a loss of 103 million yuan in Q1 [9]. Operational Challenges - In 2024, Zhongtai Automobile sold only 14 vehicles, a 98.74% decrease from 1,112 vehicles sold in 2023, and produced no vehicles compared to 1,108 in 2023 [12]. - The company is currently relying on overseas orders and is working to expand into international markets, including Algeria and Egypt, while preparing for the export of the T300 fuel version [12]. Bankruptcy and Restructuring - Zhongtai Automobile has been under bankruptcy restructuring since June 2021, with a court-approved restructuring plan in December 2021 [10]. - The company successfully removed some risk warnings in November 2022 but has struggled to fully recover, with ongoing issues related to production and operational funding [11]. Judicial Freezes and Financial Issues - Approximately 337 million shares and 27 million yuan in bank deposits have been judicially frozen by Zheshang Bank, impacting the company's operational liquidity [13]. - The company emphasizes that the frozen accounts are primarily for settling restructuring debts and do not directly affect its main operational accounts [17].
ST龙宇、ST华微陷财务困局,广济药业、祥源文旅被证监会盯上
Core Viewpoint - The article highlights the increasing regulatory scrutiny in the capital market, emphasizing a "zero tolerance" approach towards financial fraud, information disclosure violations, and fund misappropriation by listed companies. Group 1: ST Longyu - ST Longyu has been placed under investigation by the China Securities Regulatory Commission (CSRC) for suspected information disclosure violations, with a total of 8.7 billion yuan in fund misappropriation involved [1][2] - The company’s controlling shareholder and related parties have non-operational fund misappropriation totaling 9.18 billion yuan, of which 8.68 billion yuan remains unpaid [2] - The audit report for ST Longyu's 2023 annual report was issued with a "disclaimer of opinion," leading to increased delisting risks for the company [2] Group 2: ST Huamei - ST Huamei has been formally investigated by the CSRC for suspected information disclosure violations, with a self-reported non-operational fund misappropriation of 14.35 billion yuan [3][4] - The company reported significant fund flows lacking real commercial substance, with total outflows of 81.39 billion yuan and inflows of 68.52 billion yuan [3] - The ongoing investigation will impact the company's compliance risks and market reputation [3] Group 3: Guangji Pharmaceutical - Guangji Pharmaceutical has received a notice from the CSRC regarding an investigation for suspected information disclosure violations, following a previous warning from the Hubei Securities Regulatory Bureau [4][5] - The company acknowledged accounting errors in its financial reports, leading to adjustments in previously reported revenue and costs [4] - The CSRC's investigation marks an escalation in regulatory scrutiny regarding the company's compliance with information disclosure requirements [5] Group 4: Xiangyuan Cultural Tourism - Xiangyuan Cultural Tourism and its actual controller have been placed under investigation by the CSRC for suspected information disclosure violations [5] - The specific details of the violations have not yet been disclosed, but the investigation will assess the company's compliance with securities laws [5] - The outcome of the investigation is expected to be a focal point for market participants [5]
财务造假,基金出手,下调超70%!
Zhong Guo Ji Jin Bao· 2025-06-16 09:32
【导读】华夏基金下调*ST紫天估值,调整幅度超过70% 中国基金报记者 若晖 被监管出具《责令改正决定书》并实施风险警示,停牌近3个月时间,股价距2023年最高点已下跌超80%的*ST紫天,近期再遭基金公司"补刀"。 6月16日,华夏基金发布公告称,即日起,对华夏中证2000ETF持有的停牌股票"*ST紫天"按照2.50元进行估值。相比停牌前的价格,估值下调幅度超 70%。 业内人士表示,早在6月13日收盘,中证2000指数就已将*ST紫天从成份股中调出,未来该股一旦复牌,将遭遇指数基金集体卖出。而目前基金公司调整 停盘股估值,意味着基金公司认为当前停牌价格无法反映最新的基本面情况。未来不排除更多的基金公司跟进调整估值。 华夏基金下调*ST紫天估值 调整幅度超过70% 停牌接近3个月,面临退市风险的*ST紫天遭遇基金公司猛砍估值。 6月16日,华夏基金公告,停牌股票"*ST紫天"(证券代码:300280)于6月13日沪深交易所收市后由中证2000指数成份股中调出,为客观反映基金公允价 值,根据《中国证监会关于证券投资基金估值业务的指导意见》的要求,经与基金托管行协商一致,自6月16日起,华夏基金对华夏中证20 ...
000584,即将退市
新浪财经· 2025-06-13 01:13
6月12日晚,*ST工智(000584)发布公告称,公司于当日收到深交所送达的《关于江苏哈工智 能机器人股份有限公司股票终止上市的决定》,深交所决定终止公司股票上市。 公告显示,*ST工智股票自6月20日起进入退市整理期,退市整理期届满的次一交易日,深交所 对公司股票予以摘牌。 图片来源:公司公告 根据《决定》,因2023年度财务会计报告被出具无法表示意见的审计报告,*ST工智股票交易 自2024年5月6日起被实施退市风险警示。2025年4月28日,*ST工智披露被实施退市风险警示后 的首个年度报告显示,公司2024年度财务会计报告被出具无法表示意见的审计报告,财务报告 内部控制被出具否定意见的审计报告,触及深交所相关规定的股票终止上市情形。根据相关规 定,深交所决定对公司股票终止上市。 公告显示,公司股票进入退市整理期的起始日为6月20日,退市整理期为十五个交易日,预计 最后交易日为7月10日。如证券交易日期出现调整,公司退市整理期最后交易日期随之顺延。 *ST工智 年报信息显示,公司主要业务为智能制造业务,包括围绕工业机器人进行全产业链布 局,目前涵盖高端智能装备制造、工业机器人本体的制造和销售两个子板块 ...
原西凤酒董事长被提名非独立董事,*ST步森却再度辟谣西凤酒“借壳”
Hua Xia Shi Bao· 2025-06-12 12:44
Core Viewpoint - The speculation surrounding the potential reverse merger of *ST Bosen with Xifeng Liquor has intensified following the proposal for a board reshuffle, despite the company's repeated clarifications that there is no connection between the two events [2][4][8]. Group 1: Company Background and Current Situation - *ST Bosen, established in 1985, is a large apparel enterprise primarily focused on men's clothing, with its main brand being "Bosen Men's Wear" [11]. - The company has faced significant operational challenges, reporting continuous losses since 2022, with net losses of 78.45 million yuan, 67 million yuan, and 51.4 million yuan from 2022 to 2024 [11][12]. - As of the end of 2024, *ST Bosen had only 205 stores remaining nationwide, indicating a decline in its retail presence [11]. Group 2: Recent Developments - The proposal for a temporary shareholders' meeting to elect a new board and supervisory committee has been put forward by the controlling shareholder, Fangwei Tongchuang [2][3]. - Notably, several candidates for the new board have backgrounds linked to Xifeng Liquor, which has fueled speculation about a potential reverse merger [4][10]. - The company has publicly denied any connection between the board reshuffle and a reverse merger with Xifeng Liquor, emphasizing that there are no related restructuring plans [2][4][8]. Group 3: Financial Performance and Risks - *ST Bosen's stock has been marked with "delisting risk warning" due to its financial performance, with the company failing to meet certain profitability and revenue thresholds [10][12]. - The company reported a revenue of 32.345 million yuan in the first quarter of 2025, with a net loss of 4.166 million yuan [12]. - The ongoing financial struggles and the need for a turnaround are critical, as the company faces a limited timeframe to improve its financial health before potential delisting [12].
暴跌超40%!两只A股股票今天进入退市整理期
Zheng Quan Shi Bao· 2025-06-10 04:26
Group 1 - Recently, multiple companies in the A-share market have entered the delisting arrangement period, with two companies, Pengbo and Longyu, entering this period on June 10, resulting in significant stock price declines [1][2][3] - Pengbo's stock price plummeted, with a drop exceeding 64% at one point, reaching a low of 0.22 yuan, accompanied by a sharp increase in trading volume [3] - Pengbo, formerly known as Pengbo Telecom Media Group Co., Ltd., was once a well-known listed company in the A-share market, with a peak market value exceeding 60 billion yuan, now reduced to approximately 400 million yuan, representing a decline of over 99% from its historical peak [3] Group 2 - Longyu's stock also experienced a significant drop, with a decline of over 45% during trading, and its trading volume increased several times compared to previous trading days [4] - Longyu, officially known as Shanghai Longyu Data Co., Ltd., is a green digital ecological service provider and bulk commodity trading service provider, founded in 1997 [4] - Both companies received notices from the Shanghai Stock Exchange regarding the termination of their stock listings due to the issuance of audit reports that could not express an opinion on their financial statements for the fiscal year 2023 [3][4] Group 3 - Other companies are also entering the delisting arrangement period, such as Longjin Pharmaceutical, which entered on June 6, with its stock price dropping by 36.28% on that day [6] - Renrenle, a well-known supermarket chain, is set to enter the delisting arrangement period on June 13, having reported a negative net asset of 404 million yuan in its latest audited financial report [6] - Haiyue Energy is scheduled to enter the delisting arrangement period on June 16, and it is a comprehensive energy company established in 1993, primarily engaged in oil trading and related businesses [7]
*ST恒立退市前夕陷入“最后的疯狂”?拟会计差错更正试图规避退市 但公告未在证监会指定媒体上发布
Xin Lang Zheng Quan· 2025-06-06 09:47
Core Viewpoint - *ST Hengli is under investigation by the China Securities Regulatory Commission (CSRC) for suspected false disclosures in its annual report and other financial documents, facing a delisting risk due to failure to timely disclose periodic reports [1][14]. Financial Performance - *ST Hengli's revenue from 2021 to 2023 showed a significant decline, with revenues of 3.46 billion, 2.46 billion, and 1.11 billion respectively, reflecting year-on-year changes of 13.19%, -28.86%, and -54.74% [2]. - The company's net profit attributable to shareholders for the same period was 0.02 billion, -0.13 billion, and -0.11 billion, with year-on-year changes of -42.99%, -870.88%, and 13.40% [2]. Audit and Reporting Issues - The company faced challenges in its 2023 annual report, initially forecasting revenue of 1.5 billion to 1.8 billion, later revised down to 1 billion to 1.2 billion, a reduction of 33.33% [3]. - The audit report from Yongtuo Accounting Firm raised concerns about the company's ability to continue as a going concern, leading to a risk warning for delisting [3]. - *ST Hengli's failure to disclose over half of its board's assurances regarding the accuracy of the 2024 annual report resulted in a delisting risk warning from the Shenzhen Stock Exchange [3]. Legal Actions and Controversies - Following the receipt of a delisting warning, *ST Hengli filed a lawsuit against its auditing firm, Xutai, claiming damages of 38.27 million due to delays in the audit report [1][6]. - The company appointed a new auditor, Tangtang, without following the required shareholder meeting procedures, raising compliance concerns [10]. Revenue Adjustment Attempts - On May 31, *ST Hengli attempted to adjust its 2023 revenue figures by hiring Tangtang to issue a new verification report, arguing that certain income should not have been deducted [7]. - The company had previously accepted the auditor's opinion on revenue deductions without objection, leading to questions about the legitimacy of its recent claims [8]. Regulatory Compliance Issues - *ST Hengli's disclosures regarding its financial adjustments were not made through the designated media, violating regulatory requirements [13]. - The company justified its internal announcement process by claiming that relevant personnel at the Shenzhen Stock Exchange failed to disclose information in a timely manner, which does not absolve it of compliance responsibilities [13].
退市风险下实控人拟转让股份 *ST金比控制权或将变动
Zheng Quan Ri Bao· 2025-06-05 14:42
Core Viewpoint - The company *ST Jinbi is undergoing a potential change in control, with its major shareholders planning to transfer shares, which introduces both hope and uncertainty for the company's future [2][3][6] Group 1: Control Change Announcement - On June 5, *ST Jinbi announced a suspension of trading due to plans for a change in control, with the suspension expected to last no more than two trading days [2] - The change in control is currently in the negotiation stage, and there is significant uncertainty surrounding the outcome [3] Group 2: Shareholding Structure - As of the end of Q1 2025, the major shareholders Lin Haoliang and Lin Ruowen hold 27.29% and 25.95% of the shares respectively, totaling 53.24%, while the third-largest shareholder holds only 0.57% [3] Group 3: Business Overview - *ST Jinbi operates in the maternal and infant consumer goods sector, managing three proprietary brands: LABI BABY, I LOVE BABY, and BABY LABI [3] - The company has faced significant pressure on its performance due to increasing competition in the maternal and infant market [3] Group 4: Financial Performance - Since 2019, *ST Jinbi's revenue has declined from 438 million to 225 million in 2024, with net profits showing losses for three consecutive years from 2022 to 2024 [4] - The company has been under risk warning for delisting due to financial performance issues, as it met criteria for negative profit and revenue thresholds [4] Group 5: Strategic Moves - To mitigate delisting risks, *ST Jinbi has attempted to enter the medical beauty industry, acquiring stakes in Guangdong Hanfei Hospital Investment Co., Ltd. in 2021 and 2023 [5] - In 2025, the company consolidated its medical beauty operations by integrating subsidiaries, but the impact on financial performance has been limited, with a reported revenue of 76.06 million in Q1 2025, a 74.85% increase year-on-year, yet still showing a net loss [5][6]